Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H22N2O.ClH |
| Molecular Weight | 282.809 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
InChI
InChIKey=RETIMRUQNCDCQB-ZOWNYOTGSA-N
InChI=1S/C15H22N2O.ClH/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3;/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18);1H/t13-;/m0./s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1101130
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1101130
Dexivacaine is a local anesthetic drug that has minimal and non-significant side effects.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1101130 |
Primary | Unknown Approved UseUnknown |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Q6359QUC5E
Created by
admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
|
PRIMARY | |||
|
DTXSID90735374
Created by
admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
|
PRIMARY | |||
|
34333-71-6
Created by
admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
|
PRIMARY | |||
|
66586222
Created by
admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD